Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | CDK2 | P24941 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MPO | P05164 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | ALPI | P09923 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5322835 | 0.86 | ALDH1A1 (0.43) | SLC7A5CYP3A4ALDH1A1RXFP1KDM4E | |
| SCHEMBL28759590 | 0.79 | ALDH1A1 (0.50) | ALDH1A1RXFP1KDM4ECDK2LMNA | |
| SCHEMBL23779416 | 0.79 | ALDH1A1 (0.44) | ALDH1A1RXFP1KDM4ECDK2CCNT1 | |
| SCHEMBL9080043 | 0.78 | CYP1A2 (0.50) | CDK2SLC1A3 | |
| Dl-Phenylalanine SCHEMBL27773920 | 0.77 | SLC7A5 (0.51) | SLC7A5CYP3A4ALDH1A1KDM4ECDK2 | |
| SCHEMBL31618832 | 0.77 | ALDH1A1 (0.47) | CYP3A4ALDH1A1RXFP1KDM4ECDK2 | |
| SCHEMBL5325198 | 0.77 | SLC7A5 (0.47) | SLC7A5CYP3A4KDM4EHSD17B10LMNA | |
| SCHEMBL2640835 | 0.77 | ALDH1A1 (0.47) | ALDH1A1RXFP1KDM4ECDK2CCNT1 | |
| SCHEMBL28839814 | 0.76 | ALDH1A1 (0.46) | ALDH1A1RXFP1KDM4ECDK2CCNT1 | |
| SCHEMBL23409494 | 0.76 | ALDH1A1 (0.50) | ALDH1A1RXFP1KDM4ECDK2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | SLC7A5 3712/4885CYP3A4 4803/4885ALDH1A1 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.